Efficacy of dopamine agonists in dystonia.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000502:physiology*; D004311:Double-Blind Method; D004421:Dystonia / Q000188:drug therapy*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D008090:Lisuride / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010259:Paranoid Disorders / Q000139:chemically induced
D004873:Ergolines; D008090:Lisuride; D004298:Dopamine